Similar articles

• QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences.

  González-Díaz H. González-Díaz H. Curr Pharm Des. 2010;16(24):2598-600. doi: 10.2174/138161210792389261. Curr Pharm Des. 2010. PMID: 20642424 No abstract available.
• New Experimental and Computational Tools for Drug Discovery: From Chemistry to Biology. Metabolomics, Pharmacokinetics, and Medicinal Chemistry. Part - IV.

  Fiandaca MS, Gonzalez-Dominguez R, Gonzalez-Diaz H. Fiandaca MS, et al. Curr Top Med Chem. 2018;18(11):881-882. doi: 10.2174/156802661811180808095053. Curr Top Med Chem. 2018. PMID: 30182828 No abstract available.
• Medicinal Chemistry Meets Electrochemistry: Redox Potential in the Role of Endpoint or Molecular Descriptor in QSAR/QSPR.

  Nesměrák K. Nesměrák K. Mini Rev Med Chem. 2020;20(14):1341-1356. doi: 10.2174/1389557520666200204121806. Mini Rev Med Chem. 2020. PMID: 32013846 Review.
• Current computational approaches in medicinal chemistry.

  Khedkar SA. Khedkar SA. Curr Top Med Chem. 2010;10(1):1-2. doi: 10.2174/156802610790232323. Curr Top Med Chem. 2010. PMID: 20374194 No abstract available.
• From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices.

  Riera-Fernández P, Martín-Romalde R, Prado-Prado FJ, Escobar M, Munteanu CR, Concu R, Duardo-Sanchez A, González-Díaz H. Riera-Fernández P, et al. Curr Top Med Chem. 2012;12(8):927-60. doi: 10.2174/156802612800166819. Curr Top Med Chem. 2012. PMID: 22352918 Review.